SCHEMBL2073320

SCHEMBL2073320

Cc1ccc(C2=CC3CCC(C2)N3C(=O)N2CCCc3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.48
PDE4D Q08499 1/20 0.48
HSD11B1 P28845 2/20 0.47
ALDH1A1 P00352 7/20 0.47
LMNA P02545 6/20 0.47
MAPT P10636 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 3/20 0.46
HTT P42858 2/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 3/20 0.46
TSHR P16473 2/20 0.46
USP2 O75604 1/20 0.46
NOTUM Q6P988 1/20 0.45
MEN1 O00255 2/20 0.45
HPGD P15428 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2073318 1.00 PDE4B (0.48) PDE4BPDE4DHSD11B1ALDH1A1LMNA
SCHEMBL2072858 0.90 LMNA (0.47) HSD11B1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL3168844 0.90 LMNA (0.47) HSD11B1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL2072859 0.90 LMNA (0.47) HSD11B1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL2071679 0.90 POLB (0.52) PDE4BPDE4DHSD11B1ALDH1A1LMNA
SCHEMBL2071649 0.90 AVPR2 (0.47) HSD11B1SMN1; SMN2POLBTSHRNOTUM
SCHEMBL2071682 0.90 POLB (0.52) PDE4BPDE4DHSD11B1ALDH1A1LMNA
SCHEMBL2073223 0.90 PDE4B (0.48) PDE4BPDE4DHSD11B1LMNAMAPT
SCHEMBL2071651 0.90 AVPR2 (0.47) HSD11B1SMN1; SMN2POLBTSHRNOTUM
SCHEMBL2073220 0.90 PDE4B (0.48) PDE4BPDE4DHSD11B1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897773-B2 Urea derivatives of tropane, their preparation and their therapeutic application SANOFI-AVENTIS (FR) 2011-03-01 US disclosed
US-20100324084-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2010-12-23 US disclosed
EP-2046791-B1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2010-03-24 EP disclosed
US-20090170894-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2009-07-02 US disclosed
EP-2046791-A2 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION Sanofi-Aventis (FR) 2009-04-15 EP disclosed
WO-2008000951-A2 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2008-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170894-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HSD11B1, ADRA1D, HSD17B1 PDE4B 287/4885PDE4D 292/4885HSD11B1 1/4885
US-20100324084-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HSD11B1, ADRA1D, HSD17B1 PDE4B 287/4885PDE4D 292/4885HSD11B1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.